We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

32 hedge funds and large institutions have $23.2M invested in Marrone Bio Innovations, Inc. in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $22.6M → $23.2M (+$594K)

16% less funds holding

Funds holding: 38 → 32 (-6)

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
13
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$41.6K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$27K
3
SM
Senvest Management
New York
+$25.2K
4
BFA
BlackRock Fund Advisors
California
+$16.6K
5
UBS Group
UBS Group
Switzerland
+$14.4K

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$207K
2
CS
Credit Suisse
Switzerland
-$128K
3
Deutsche Bank
Deutsche Bank
Germany
-$107K
4
PPA
Parametric Portfolio Associates
Washington
-$97K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$89.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$10.1M – – –
Primecap Management
2
Primecap Management
California
$6.84M – – –
SM
3
Senvest Management
New York
$3.25M +$25.2K +12,924 +0.8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$855K +$2.38K +1,223 +0.3%
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$418K +$27K +13,844 +8%
Millennium Management
6
Millennium Management
New York
$392K -$2.53K -1,300 -0.7%
BCM
7
Bridgeway Capital Management
Texas
$170K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$161K +$156 +80 +0.1%
AIG
9
American International Group
New York
$151K +$125 +64 +0.1%
Goldman Sachs
10
Goldman Sachs
New York
$145K -$4.39K -2,251 -3%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$139K -$89.3K -45,856 -41%
SCM
12
Seamans Capital Management
Massachusetts
$127K – – –
BFA
13
BlackRock Fund Advisors
California
$102K +$16.6K +8,529 +21%
Morgan Stanley
14
Morgan Stanley
New York
$88K -$990 -508 -1%
Northern Trust
15
Northern Trust
Illinois
$46K -$207K -106,045 -83%
Citadel Advisors
16
Citadel Advisors
Florida
$45K +$41.6K +21,346 New
SIP
17
Stoneridge Investment Partners
Pennsylvania
$32K -$1.68K -860 -5%
ARTA
18
A.R.T. Advisors
New York
$25K -$21.4K -11,000 -48%
State Street
19
State Street
Massachusetts
$23K -$34.5K -17,700 -62%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$23K – – –
UBS Group
21
UBS Group
Switzerland
$16K +$14.4K +7,405 New
TRCT
22
Tower Research Capital (TRC)
New York
$12K -$1.05K -539 -9%
BIM
23
BlackRock Investment Management
Delaware
$9K – – –
New York State Common Retirement Fund
24
New York State Common Retirement Fund
New York
$8K -$15.6K -7,994 -68%
LTFS
25
Ladenburg Thalmann Financial Services
Florida
$5K -$604 -310 -10%
1
2

MBII Hedge Fund Activity: Q3 2015 in Review

32 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2015, worth a combined $23.2M — up 2.6% from $22.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of MBII and 4 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 6 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $41.6K. The largest seller was Northern Trust, cutting an estimated $207K.

  • 32 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2015, down from 38 in Q2 2015.
  • Funds reported $23.2M of Marrone Bio Innovations, Inc. stock for Q3 2015, up 2.6% quarter-over-quarter.
  • 4 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2015 and 10 closed out, a net change of -6 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q3 2015 was Citadel Advisors, an estimated $41.6K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q3 2015 was Northern Trust, an estimated $207K sold.

Based on aggregated 13F filings for Q3 2015.